Back to search

Peptide record

TPDB43062

T Peptide Anticancer standard
19 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB43062
T Peptide
Anticancer
Cancer-related peptides
CancerPPD 2.0 Peptipedia SATPdb dbACP
standard
No
A 19-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, Peptipedia, SATPdb, and other sources, with an available 3D structural model.
Sequence
TKPRKTKPRKTKPRKTKPR
Physicochemical Analysis
C102H190N38O24
ANDCEQGHILMFSWYV
K
2332.87
12.89
11
0
0
+11
12.53
-2.868
0.00
Mammalian: 7.2 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
4
Residue Composition
number
0
A
4
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
0
I
0
L
7
K
0
M
0
F
4
P
0
S
4
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 4 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 0 K: 7 M: 0 F: 0 P: 4 S: 0 T: 4 W: 0 Y: 0 V: 0
Chemical Descriptors
19
C102H190N38O24
2332.87
12.89
+11
12.53
-2.868
Free
L
Linear
Free
Anticancer
Tuftsin derivative
Evidence Records 3 records
Evidence 1 Activity

Activity

69.6% maximum inhibitory rate at 8 mg/kg
Anticancer

Target

Liver Cancer
HepG-2
Liver

Assay & Model

MTT/MTS assay
48-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2014

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

70% maximum inhibitory rate at 8 mg/kg
Anticancer

Target

Colon Cancer
HT-29
Colon

Assay & Model

MTT/MTS assay
48-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2014
Evidence 3 Activity

Activity

67.2% maximum inhibitory rate at 8 mg/kg
Anticancer

Target

Gastric Cancer
BGC-823
Stomach

Assay & Model

MTT/MTS assay
48-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2014